HR 2820
114th Congress
House
Health
Administrative law and regulatory procedures
Blood and blood diseases
Cell biology and embryology
Department of Health and Human Services
Health programs administration and funding
Medical research
Organ and tissue donation and transplantation
Public contracts and procurement
Research administration and funding
Stem Cell Therapeutic and Research Reauthorization Act of 2015
Introduced: June 18, 2015
Introduced by:
Smith, Christopher H.
Republican
· New Jersey
See on congress.gov
Everywhere this bill has been
31 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 2015
Became Public Law No: 114-104.
Dec 18, 2015
Signed by President.
Dec 18, 2015
Presented to President.
Dec 16, 2015
Motion to reconsider laid on the table Agreed to without objection.
Dec 16, 2015
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695). (text as House agreed to Senate amendment: CR H9333)
Dec 16, 2015
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695).(text as House agreed to Senate amendment: CR H9333)
Dec 16, 2015
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
Dec 16, 2015
DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and concur in the Senate amendment to H.R. 2820.
Dec 16, 2015
Mr. Pitts moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H9333-9335, H9339)
Dec 10, 2015
Message on Senate action sent to the House.
Dec 9, 2015
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S8560; text as passed Senate: CR S8560)
Dec 9, 2015
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S8560; text as passed Senate: CR S8560)
Dec 3, 2015
Placed on Senate Legislative Calendar under General Orders. Calendar No. 311.
Dec 3, 2015
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Nov 18, 2015
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Sep 9, 2015
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 8, 2015
Motion to reconsider laid on the table Agreed to without objection.
Sep 8, 2015
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5801)
Sep 8, 2015
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5801)
Sep 8, 2015
DEBATE - The House proceeded with forty minutes of debate on H.R. 2820.
Sep 8, 2015
Considered under suspension of the rules. (consideration: CR H5801-5804)
Sep 8, 2015
Mr. Guthrie moved to suspend the rules and pass the bill.
Sep 8, 2015
Placed on the Union Calendar, Calendar No. 183.
Sep 8, 2015
Reported by the Committee on Energy and Commerce. H. Rept. 114-242.
Jul 29, 2015
Ordered to be Reported by Voice Vote.
Jul 29, 2015
Committee Consideration and Mark-up Session Held.
Jul 23, 2015
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jul 23, 2015
Subcommittee Consideration and Mark-up Session Held.
Jun 19, 2015
Referred to the Subcommittee on Health.
Jun 18, 2015
Referred to the House Committee on Energy and Commerce.
Jun 18, 2015
Introduced in House
Votes taken on this bill
1
| Date | Chamber | What was voted on | Result | Yes–No | |
|---|---|---|---|---|---|
| Dec 16, 2015 | House · vote #695 | On Motion to Suspend the Rules and concur in the Senate Amendment | Passed | 421–0 | See who voted → |
Plain-English summary
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.)
Stem Cell Therapeutic and Research Reauthorization Act of 2015
(Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program.
(Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised.
(Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
What's happening now
Became Public Law No: 114-104.
Committees of jurisdiction
3